4D Molecular Therapeutics — Returns

$Open the interactive terminal to run `audit returns` with custom options.→

Capital Flow Returns Earning Quality Debt Discipline Moat

Key Metrics

US.FDMT · YoY: 2026 H1 vs 2025 H1

Metric	Value	YoY
ROE	-34.8%	↓

Unlock Full Report

Sign up or upgrade to view the complete audit analysis.